3DBio Therapeutics

Company Summary

3D Bio is a leading-edge bioprinting company, focusing on therapeutics with near-term clinical applications. 3D Bio Corporation is shaping possibilities – to print what the body cannot heal. 3D Bio seeks a world in which healthy living tissue is no longer in short supply, and to open new paradigms for surgically healing patients. The company was founded by Cornell Professor Larry Bonassar and Columbia Professor Hod Lipson, and a business team of senior McKinsey & Company alumni.

Year Founded:  2015

Key Executives:
• Dr. Larry Bonassar, Co-Founder
• Hod Lipson, Co-Founder

Location:  New York, NY

Website:  https://3dbiocorp.com/

Company Status:  Private

Year Invested:  2017

Investment Status:  Current